Premier Biomedical Reformulates CBD Products

Cannabis Investing News

Premier Biomedical is increasing the CBD in its CBD Hemp Oil 96-hour Skin Patch and oil-based CBD Hemp Oil Roll-on products.

Premier Biomedical (OTCQB:BIEI) is increasing the CBD in its CBD Hemp Oil 96-hour Skin Patch and oil-based CBD Hemp Oil Roll-on products.
As quoted in the press release:

The skin patch is increasing its CBD content to 50 mg, while maintaining its current selling price of $20. Roll-on applicators are currently available in two forms — 110 mg CBD oil-based with sage scent, and 120mg CBD water-based lavender scent. A new, stronger oil-based sage scented roll-on with 150mg of CBD will be available by the end of the third quarter. These higher content CBD products will be available through their website, www.painreliefmeds.com, and at select pharmacies and pain & wellness centers.
William Hartman CEO and President of Premier Biomedical stated, “We have decided to make these improvements so that we can provide the highest level of CBD for comparable products to our customers, along with increased value. Our mission is to continuously improve our products and expand our product offerings to meet the needs of our customers.”
“Based on feedback from our customers, through unsolicited reviews and testimonials on our website, we are encouraged that these products can be a possible replacement for dangerous opioid pain relief narcotics for many types of pain.”

Click here to read the full press release.

Source: www.marketwired.com

The Conversation (0)
×